Compile Data Set for Download or QSAR
maximum 50k data
Found 464 with Last Name = 'baik' and Initial = 't'
LigandPNGBDBM50393357(CHEMBL2152148)
Affinity DataIC50:  5nMAssay Description:Inhibition of human PI3Kgamma expressed in sf9 cells assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50393365(CHEMBL2152257)
Affinity DataIC50:  6nMAssay Description:Inhibition of human PI3Kgamma expressed in sf9 cells assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50393359(CHEMBL2152150)
Affinity DataIC50:  8nMAssay Description:Inhibition of human PI3Kgamma expressed in sf9 cells assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50393333(CHEMBL2151050)
Affinity DataIC50:  10nMAssay Description:Inhibition of human PI3Kgamma expressed in sf9 cells assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50393348(CHEMBL2152139)
Affinity DataIC50:  11nMAssay Description:Inhibition of human PI3Kgamma expressed in sf9 cells assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50393339(CHEMBL2152131)
Affinity DataIC50:  17nMAssay Description:Inhibition of human PI3Kgamma expressed in sf9 cells assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50393334(CHEMBL2152126)
Affinity DataIC50:  18nMAssay Description:Inhibition of human PI3Kgamma expressed in sf9 cells assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assayMore data for this Ligand-Target Pair
LigandPNGBDBM50393335(CHEMBL2152127)
Affinity DataIC50:  18nMAssay Description:Inhibition of human PI3Kgamma expressed in sf9 cells assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50393353(CHEMBL2152144)
Affinity DataIC50:  18nMAssay Description:Inhibition of human PI3Kgamma expressed in sf9 cells assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50393342(CHEMBL2152252)
Affinity DataIC50:  18nMAssay Description:Inhibition of human PI3Kgamma expressed in sf9 cells assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assayMore data for this Ligand-Target Pair
LigandPNGBDBM50393360(CHEMBL2152250)
Affinity DataIC50:  18nMAssay Description:Inhibition of human PI3Kgamma expressed in sf9 cells assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50393364(CHEMBL2152256)
Affinity DataIC50:  20nMAssay Description:Inhibition of human PI3Kgamma expressed in sf9 cells assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50393354(CHEMBL2152145)
Affinity DataIC50:  20nMAssay Description:Inhibition of human PI3Kgamma expressed in sf9 cells assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Exelixis

Curated by ChEMBL
LigandPNGBDBM50486035(CHEMBL2204498)
Affinity DataIC50:  21nMAssay Description:Displacement of biotinylated geldanamycin from human His-tagged Hsp90 by TR-FRET assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
LigandPNGBDBM50393358(CHEMBL2152149)
Affinity DataIC50:  21nMAssay Description:Inhibition of human PI3Kgamma expressed in sf9 cells assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50393332(CHEMBL2152125)
Affinity DataIC50:  21nMAssay Description:Inhibition of human PI3Kgamma expressed in sf9 cells assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assayMore data for this Ligand-Target Pair
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Exelixis

Curated by ChEMBL
LigandPNGBDBM50486034(CHEMBL2204501)
Affinity DataIC50:  21nMAssay Description:Displacement of biotinylated geldanamycin from human His-tagged Hsp90 by TR-FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Exelixis

Curated by ChEMBL
LigandPNGBDBM50486032(CHEMBL2204497)
Affinity DataIC50:  24nMAssay Description:Displacement of biotinylated geldanamycin from human His-tagged Hsp90 by TR-FRET assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Exelixis

Curated by ChEMBL
LigandPNGBDBM50486033(CHEMBL2204502)
Affinity DataIC50:  24nMAssay Description:Displacement of biotinylated geldanamycin from human His-tagged Hsp90 by TR-FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Exelixis

Curated by ChEMBL
LigandPNGBDBM50486036(CHEMBL2204496)
Affinity DataIC50:  25nMAssay Description:Displacement of biotinylated geldanamycin from human His-tagged Hsp90 by TR-FRET assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Exelixis

Curated by ChEMBL
LigandPNGBDBM50486041(CHEMBL2204500)
Affinity DataIC50:  25nMAssay Description:Displacement of biotinylated geldanamycin from human His-tagged Hsp90 by TR-FRET assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
LigandPNGBDBM50393355(CHEMBL2152146)
Affinity DataIC50:  26nMAssay Description:Inhibition of human PI3Kgamma expressed in sf9 cells assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50393340(CHEMBL2152132)
Affinity DataIC50:  26nMAssay Description:Inhibition of human PI3Kgamma expressed in sf9 cells assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Exelixis

Curated by ChEMBL
LigandPNGBDBM50486042(CHEMBL2204499)
Affinity DataIC50:  27nMAssay Description:Displacement of biotinylated geldanamycin from human His-tagged Hsp90 by TR-FRET assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Exelixis

Curated by ChEMBL
LigandPNGBDBM50486043(CHEMBL2204504)
Affinity DataIC50:  28nMAssay Description:Displacement of biotinylated geldanamycin from human His-tagged Hsp90 by TR-FRET assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
LigandPNGBDBM50393351(CHEMBL2152142)
Affinity DataIC50:  31nMAssay Description:Inhibition of human PI3Kgamma expressed in sf9 cells assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50393329(CHEMBL2152253)
Affinity DataIC50:  34nMAssay Description:Inhibition of human PI3Kgamma expressed in sf9 cells assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50393333(CHEMBL2151050)
Affinity DataIC50:  38nMAssay Description:Inhibition of human PI3Kalpha expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescen...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Exelixis

Curated by ChEMBL
LigandPNGBDBM50486037(CHEMBL2204503)
Affinity DataIC50:  38nMAssay Description:Displacement of biotinylated geldanamycin from human His-tagged Hsp90 by TR-FRET assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
LigandPNGBDBM50393365(CHEMBL2152257)
Affinity DataIC50:  39nMAssay Description:Inhibition of human PI3Kbeta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescenc...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50393338(CHEMBL2152130)
Affinity DataIC50:  39nMAssay Description:Inhibition of human PI3Kgamma expressed in sf9 cells assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHeat shock protein HSP 90-alpha/90-beta(Homo sapiens (Human))
Exelixis

Curated by ChEMBL
LigandPNGBDBM50486038(CHEMBL2204525)
Affinity DataIC50:  40nMAssay Description:Displacement of biotinylated geldanamycin from human His-tagged Hsp90 by TR-FRET assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
The Asan Foundation

US Patent
LigandPNGBDBM355876(N-(4-((5-(3-cyanomethylphenyl)pyrrolo[1,2-b]pyrida...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
The Asan Foundation

US Patent
LigandPNGBDBM355854(4-ethoxy-N-(3-fluoro-4-((5-(3-formylphenyl)pyrrolo...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
The Asan Foundation

US Patent
LigandPNGBDBM355855(N-(3-fluoro-4-((5-(3-hydroxymethyl)phenyl)pyrrolo[...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
The Asan Foundation

US Patent
LigandPNGBDBM355856(4-ethoxy-N-(3-fluoro-4-((5-(3-(2-hydroxypropan-2-y...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
The Asan Foundation

US Patent
LigandPNGBDBM355857(4-ethoxy-N-(3-fluoro-4-((5-(3-(1-hydroxyethyl)phen...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
The Asan Foundation

US Patent
LigandPNGBDBM355858(N-(3-fluoro-4-((5-(3-(1-hydroxyethyl)phenyl)pyrrol...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
The Asan Foundation

US Patent
LigandPNGBDBM355859(4-ethoxy-N-(3-fluoro-4-((5-(pyrimidin-5-yl)pyrrolo...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
The Asan Foundation

US Patent
LigandPNGBDBM355860(4-ethoxy-N-(3-fluoro-4-((5-(3-morpholin-4-carbonyl...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
The Asan Foundation

US Patent
LigandPNGBDBM355861(4-ethoxy-N-(3-fluoro-4-((5-(3-aminophenyl)pyrrolo[...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
The Asan Foundation

US Patent
LigandPNGBDBM355862(N-(4-((5-(3-((dimethylamino)methyl)phenyl)pyrrolo[...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
The Asan Foundation

US Patent
LigandPNGBDBM355863(N-(4-((5-(3-((dimethylamino)methyl)phenyl)pyrrolo[...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
The Asan Foundation

US Patent
LigandPNGBDBM355864(N-(4-((5-(3-amino-5-cyanophenyl)pyrrolo[1,2-b]pyri...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
The Asan Foundation

US Patent
LigandPNGBDBM355865(N-(4-((5-(3-aminomethylphenyl)pyrrolo[1,2-b]pyrida...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
The Asan Foundation

US Patent
LigandPNGBDBM355866(N-(4-((5-(3-(ethylamino)phenyl)pyrrolo[1,2-b]pyrid...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
The Asan Foundation

US Patent
LigandPNGBDBM355867(N-(4-((5-(2-chloro-5-((dimethylamino)methyl)phenyl...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
The Asan Foundation

US Patent
LigandPNGBDBM355868(N-(4-((5-(5-((dimethylamino)methyl)-2-fluorophenyl...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
The Asan Foundation

US Patent
LigandPNGBDBM355869(N-(4-((5-(3-((dimethylamino)methyl)-5-fluorophenyl...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
The Asan Foundation

US Patent
LigandPNGBDBM355870(N-(4-((5-(3-amino-4-methyl)-5-fluorophenyl)pyrrolo...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 464 total ) | Next | Last >>
Jump to: